General Folders Inc.

SAN FRANCISCO, CA · Founded 2021 · CIK 0001991515 · Biotech

Oral GLP-1 peptide formulation and portable bioreactor platform for peptide production

general.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$20K
1 Form D · Aug 2023
37 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$20,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2113ABILITY DYNAMICS, L.L.C.—$1.5M
2114REPRODUCTIVE STRESS; MEASUREMENT, MECHANISMS AND MANAGEMENT, CORPORATION——
2115BRIACELL THERAPEUTICS CORP—$34M
2116General Folders Inc.—$20K
2117Renasant Bio—$55M
2118PIXIMUNE, INC.——
2119DFI Holding Inc.—$55M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Pardis NoorzadDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.